
The webinar will be held on Thursday 19th October 2023 at 11:00am AEDT / 10:30am ACDT / 8:00am AWST
For the Q&A session, investors are invited to send questions for the webinar prior to 9:00am AEDT Thursday 19th October 2023 to: dirk@candouradvisory.com.au
Register for the webinar at the link below:
https://www.abnnewswire.net/lnk/LZPI0VFS
After registering, you will receive a confirmation email containing information about joining the webinar. A recording will be available at the above link shortly after the conclusion of the live session.
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
Contact
Dr. David BrookesChair, Anatara Lifesciences Ltd
+61 (0) 411 712 579
dbrookes@anatara.com
Dirk van Dissel
Candour Advisory - Investor Relations
+61 (0) 408 326 367
dirk@candouradvisory.com.au
Related Companies